ACCESS DAXXIFY

Serial Number 98256358
Registration 7883786
700

Registration Progress

Application Filed
Nov 6, 2023
Under Examination
Oct 29, 2024
Approved for Publication
Sep 3, 2024
Published for Opposition
Sep 3, 2024
Registered
Aug 5, 2025

Trademark Image

ACCESS DAXXIFY

Basic Information

Serial Number
98256358
Registration Number
7883786
Filing Date
November 6, 2023
Registration Date
August 5, 2025
Published for Opposition
September 3, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 5, 2025
Registration
Registered
Classes
036

Rights Holder

Revance Therapeutics, Inc.

03
Address
207 Mockingbird Lane
Johnson City, TN 37604

Ownership History

Revance Therapeutics, Inc.

Original Applicant
03
Newark, CA

Revance Therapeutics, Inc.

Owner at Publication
03
Johnson City, TN

Revance Therapeutics, Inc.

Original Registrant
03
Johnson City, TN

Legal Representation

Attorney
Jennifer Waitman

USPTO Deadlines

Next Deadline
2015 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250805)
Due Date
August 05, 2031
Grace Period Ends
February 05, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Aug 5, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 5, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 30, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 30, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 30, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 30, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 30, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 16, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 14, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 14, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 15, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 12, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 2, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 15, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 29, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 3, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 3, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 14, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 31, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 27, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 27, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 27, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 17, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 17, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 17, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 14, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 1, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 9, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 036
Financial management of patient reimbursement programs; Financial administration of medication reimbursement programs; Providing patient financial support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing insurance claims processing information in the nature of information about insurance authorization forms and appeals, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims
First Use Anywhere: May 7, 2024
First Use in Commerce: May 7, 2024

Classification

International Classes
036